The coronavirus pandemic is throwing a spotlight on stocks in the U.S. healthcare sector, home to the companies that could develop treatments, vaccines and improved diagnostics needed to tackle the greatest public health crisis in a century.
“Beware the ides of March,” a soothsayer told Julius Caesar in Shakespeare’s famous play of the same name. Whether you believe in superstitions or not, March of 2020 will go down as a historic month on Wall Street. After peaking on February 19th, the S&P 500 fell 34% in just 23 trading days, marking the fastest bear market ever.
Foundations and endowments are taking a cautious approach to the markets and when to capitalize on upcoming investment opportunities the coronavirus pandemic will provide long-term investors.